D
Deenan Pillay
Researcher at University College London
Publications - 427
Citations - 25892
Deenan Pillay is an academic researcher from University College London. The author has contributed to research in topics: Population & Drug resistance. The author has an hindex of 77, co-authored 417 publications receiving 23451 citations. Previous affiliations of Deenan Pillay include Brighton and Sussex Medical School & St George's Hospital.
Papers
More filters
Update of the Drug Resistance Mutations in HIV-1.
Victoria A. Johnson,F. Brun-Vezinet,Bonaventura Clotet,Huldrych F. Günthard,Daniel R. Kuritzkes,Deenan Pillay,Jonathan M. Schapiro,Douglas D. Richman +7 more
TL;DR: The International AIDS Society-USA (IAS-USA) Drug Resistance Mutations Group reviews new data on HIV-1 drug resistance that have been published or presented at recent scientific meetings to maintain a current list of mutations associated with antiretroviral drug resistance.
Journal ArticleDOI
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
Brian Gazzard,Jane Anderson,Abdel Babiker,Marta Boffito,Gary Brook,Gary Brough,Duncan Churchill,Ben Cromarty,Satyajit Das,Martin Fisher,Andrew L. Freedman,Anna Maria Geretti,Margaret A. Johnson,Saye Khoo,Clifford Leen,Devaki Nair,Barry Peters,Andrew N. Phillips,Deenan Pillay,Anton Pozniak,John P. Walsh,Ed Wilkins,Ian S. Williams,Matthew Williams,M Youle +24 more
TL;DR: The 2008 BHIVA Guidelines have been updated to incorporate all the new relevant information since the last iteration and all the peer-reviewed publications and important, potentially treatment-changing abstracts from the last 2 years have been reviewed.
Journal ArticleDOI
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
Diane E Bennett,Ricardo Jorge Camacho,Dan Otelea,Daniel R. Kuritzkes,Hervé Fleury,Mark Kiuchi,Walid Heneine,Rami Kantor,Michael R. Jordan,Jonathan M. Schapiro,Anne-Mieke Vandamme,Paul Sandstrom,Charles A. Boucher,Charles A. Boucher,David A. M. C. van de Vijver,Soo-Yon Rhee,Tommy F. Liu,Deenan Pillay,Robert W. Shafer +18 more
TL;DR: This paper follows the same procedures described previously to develop an updated list of SDRMs that are likely to be useful for ongoing and future studies of transmitted drug resistance and concludes that the updated SDRM list has 93 mutations.
Journal ArticleDOI
Digital technologies in the public-health response to COVID-19.
Jobie Budd,Jobie Budd,Benjamin S. Miller,Erin M. Manning,Vasileios Lampos,Mengdie Zhuang,Michael Edelstein,Geraint Rees,Vincent C. Emery,Molly M. Stevens,Neil Keegan,Michael J. Short,Deenan Pillay,Ed Manley,Ingemar J. Cox,Ingemar J. Cox,David L Heymann,Anne M Johnson,Rachel A. McKendry,Rachel A. McKendry +19 more
TL;DR: The future of public health is likely to become increasingly digital, and the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases is reviewed.
Journal Article
High rates of forward transmission events after acute/early HIV-1 infection. Commentary
Deenan Pillay,Martin Fisher,Bluma G. Brenner,Michel Roger,Jean-Pierre Routy,Daniela Moisi,Michel Ntemgwa,Claudine Matte,Jean-Guy Baril,Réjean Thomas,Danielle Rouleau,Julie Bruneau,Roger LeBlanc,Mario Legault,Cécile Tremblay,Hugues Charest,Mark A. Wainberg +16 more
TL;DR: In this article, a population-based phylogenetic approach was used to characterize human immunodeficiency virus (HIV)-transmission dynamics in Quebec, where early infection accounts for approximately half of onward transmissions in this urban North American study.